[Intravesical instillation of adriamycin in the aftertreatment of transurethrally resected carcinoma of the urinary bladder (author's transl)].
32 patients whose condition was diagnosed as carcinoma of the urinary bladder were subjected to weekly intravesical instillation treatment with adriamycin for a period of 6 weeks after transurethral resection of the tumours. The oncolytic and thus recurrence-preventive value of treatment was determined by endoscopic controls with exploratory excisions. All in all a persistent tumour was found in 31% of the cases and a recurrence-free course in 69% over a minimum observation period of 1 year. These results are definitely better than those for comparable instillation treatments with surface-active or immunologically active substances.
D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000601:surgery; D004317:Doxorubicin / Q000008:administration & dosage*; D004724:Endoscopy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011182:Postoperative Care; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery
D004317:Doxorubicin
Intravesikale Instillationsnachbehandlung transurethral resezierter Harnblasenkarzinome mit Adriamycin.